BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32761777)

  • 1. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
    Zhou X; Brooks M; Jiang P; Koga S; Zuberi AR; Baker MC; Parsons TM; Castanedes-Casey M; Phillips V; Librero AL; Kurti A; Fryer JD; Bu G; Lutz C; Dickson DW; Rademakers R
    EMBO Rep; 2020 Oct; 21(10):e50197. PubMed ID: 32761777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
    Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A
    EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
    Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F
    EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
    Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
    Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM
    Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
    Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
    Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.
    Zhou X; Kukar T; Rademakers R
    Adv Exp Med Biol; 2021; 1281():219-242. PubMed ID: 33433878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
    Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
    Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
    Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
    Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
    Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
    Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
    Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
    Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity.
    Nicholson AM; Zhou X; Perkerson RB; Parsons TM; Chew J; Brooks M; DeJesus-Hernandez M; Finch NA; Matchett BJ; Kurti A; Jansen-West KR; Perkerson E; Daughrity L; Castanedes-Casey M; Rousseau L; Phillips V; Hu F; Gendron TF; Murray ME; Dickson DW; Fryer JD; Petrucelli L; Rademakers R
    Acta Neuropathol Commun; 2018 May; 6(1):42. PubMed ID: 29855382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.